Leaflet MEMANTINA TEVA 10mg / ml oral solution

Product code:
W60646004
Quantity:
1
Indicated for:
Alzheimer's disease; dementia
Route of administration:
oral
Substance:
memantine (NMDA receptor antagonist)
ATC
N06DX01 — Nervous system | Anti-dementia drugs | Other anti-dementia drugs
Memantine is a medication used to treat moderate to severe dementia associated with Alzheimer’s disease. It works by blocking NMDA (N-methyl-D-aspartate) receptors in the brain, reducing the excessive effects of glutamate, a neurotransmitter that, in high amounts, can contribute to nerve cell damage.

Memantine helps improve cognitive function, memory, and the ability to perform daily activities, but it does not cure Alzheimer’s disease. It is usually administered in tablet or oral solution form, with the dose gradually adjusted to minimize side effects.

Side effects may include dizziness, headaches, constipation, drowsiness, or confusion. In rare cases, hallucinations or high blood pressure may occur. It is important to take the medication as prescribed by a doctor, with regular monitoring of the patient’s condition.

General data about MEMANTINA TEVA 10mg / ml

Substance:
memantine
Date of latest medicines list:
01-03-2024
Product code:
W60646004
Concentration:
10mg / ml
Pharmaceutical form:
oral solution
Quantity:
1
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
TEVA PHARM. WORKS PRIVATE LTD. COMPANY - UNGARIA
Holder:
TEVA PHARMACEUTICALS S.R.L. - ROMANIA
Number:
10927/2018/01
Shelf life:
3 years-after packing for marketing; after the first opening of the bottle-12 sapatamani

Concentrations available for memantine

  • 10mg
  • 10mg/g
  • 10mg/ml
  • 15mg
  • 20mg
  • 5mg
  • 5mg/10mg/15mg/20mg
  • 5mg/dose
  • 5mg/dose eliberata